FDA approves Click’s digital therapeutic for episodic migraine More than 37 million adults in the US are affected by migraine
FDA approves Deciphera’s Romvimza for rare tumour type Tenosynovial giant cell tumours can cause pain, stiffness, swelling and movement limitations